Literature DB >> 12121471

Expression and roles of herpesvirus entry mediators A and C in cells of oral origin.

S-L Hung1, Y-Y Cheng, Y-H Wang, K-W Chang, Y-T Chen.   

Abstract

The roles of viral glycoprotein D (gD) and cellular herpesvirus entry mediators A (HveA) and C (HveC) in herpes simplex virus entry into oral cells were determined. Studies with purified truncated forms of gD-1, HveA and HveC indicated that these molecules may be involved in herpes simplex virus entry into oral cells. Moreover, HveA was expressed similarly in primary cultures of gingival keratinocytes and fibroblasts, whereas HveC was expressed at higher levels in gingival keratinocytes, as determined by RT-PCR and immunocytochemical staining. Further analysis using immunohistochemistry demonstrated that both HveA and HveC were expressed in epithelial cells, fibroblasts and vascular endothelial cells in gingival tissues. However, only HveC was detected in nerve fibers. Also, HveA was detected throughout the epidermis, whereas HveC was pronounced in the strata basale and spinosum. In conclusion, this study characterized HveA and HveC, molecules that may participate in entry of herpes simplex virus into oral cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12121471     DOI: 10.1034/j.1399-302x.2002.170403.x

Source DB:  PubMed          Journal:  Oral Microbiol Immunol        ISSN: 0902-0055


  9 in total

1.  Herpes simplex virus type 1 enters human epidermal keratinocytes, but not neurons, via a pH-dependent endocytic pathway.

Authors:  Anthony V Nicola; Jean Hou; Eugene O Major; Stephen E Straus
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

2.  Mechanical Barriers Restrict Invasion of Herpes Simplex Virus 1 into Human Oral Mucosa.

Authors:  Katharina Thier; Philipp Petermann; Elena Rahn; Daniel Rothamel; Wilhelm Bloch; Dagmar Knebel-Mörsdorf
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

3.  Cbl E3 Ligase Mediates the Removal of Nectin-1 from the Surface of Herpes Simplex Virus 1-Infected Cells.

Authors:  Thibaut Deschamps; Christos Dogrammatzis; Ranajoy Mullick; Maria Kalamvoki
Journal:  J Virol       Date:  2017-05-26       Impact factor: 5.103

4.  Herpes simplex virus glycoprotein D interferes with binding of herpesvirus entry mediator to its ligands through downregulation and direct competition.

Authors:  Katie M Stiles; J Charles Whitbeck; Huan Lou; Gary H Cohen; Roselyn J Eisenberg; Claude Krummenacher
Journal:  J Virol       Date:  2010-09-08       Impact factor: 5.103

5.  Nectin-1/HveC Mediates herpes simplex virus type 1 entry into primary human sensory neurons and fibroblasts.

Authors:  Scott A Simpson; Michael D Manchak; Elizabeth J Hager; Claude Krummenacher; J Charles Whitbeck; Myron J Levin; Curt R Freed; Christine L Wilcox; Gary H Cohen; Roselyn J Eisenberg; Lewis I Pizer
Journal:  J Neurovirol       Date:  2005-04       Impact factor: 2.643

6.  Glycoprotein D actively induces rapid internalization of two nectin-1 isoforms during herpes simplex virus entry.

Authors:  Katie M Stiles; Claude Krummenacher
Journal:  Virology       Date:  2010-01-20       Impact factor: 3.616

7.  The herpes simplex virus receptor nectin-1 is down-regulated after trans-interaction with glycoprotein D.

Authors:  Katie M Stiles; Richard S B Milne; Gary H Cohen; Roselyn J Eisenberg; Claude Krummenacher
Journal:  Virology       Date:  2008-02-20       Impact factor: 3.616

8.  Entry mechanisms of herpes simplex virus 1 into murine epidermis: involvement of nectin-1 and herpesvirus entry mediator as cellular receptors.

Authors:  Philipp Petermann; Katharina Thier; Elena Rahn; Frazer J Rixon; Wilhelm Bloch; Semra Özcelik; Claude Krummenacher; Martin J Barron; Michael J Dixon; Stefanie Scheu; Klaus Pfeffer; Dagmar Knebel-Mörsdorf
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

9.  Saliva enhances infection of gingival fibroblasts by herpes simplex virus 1.

Authors:  Yi Zuo; J Charles Whitbeck; Gabriel J Haila; Abraham A Hakim; Paul W Rothlauf; Roselyn J Eisenberg; Gary H Cohen; Claude Krummenacher
Journal:  PLoS One       Date:  2019-10-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.